US2022133816A1PendingUtilityA1
Feed additive formulation and methods of making and using the same
Est. expiryMar 7, 2037(~10.6 yrs left)· nominal 20-yr term from priority
A61K 47/02A23K 50/30A61K 2035/115C12Y 302/01008A61P 33/02A23K 10/18A61P 1/14A23K 20/189A23K 50/75A61K 9/0056A61K 35/742A61P 31/04A23K 20/24A61K 38/47C12N 1/20
46
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The presently disclosed subject matter relates to feed additive formulations for monogastric animal feed. Particularly, the disclosed formulations comprise an isolated xylanase enzyme and a B. licheniformis strain PWD-1. The feed additive formulations may further include B. amyloliquefaciens strain Ba-BPD1. The disclosed formulations are useful for addition to feeds for monogastric animals to synergistically improve the performance of the animals.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . A feed additive formulation for monogastric animal feed, the formulation comprising an isolated xylanase enzyme and a biologically pure culture of a Bacillus licheniformis strain PWD-1 (Accession No. 53757), or a mutant thereof having all the identifying characteristics thereof.
2 . The feed additive formulation of claim 1 , further comprising a biologically pure culture of a Bacillus amyloliquefaciens strain Ba-BPD1 (Accession No. DSM 21836), or a mutant thereof having all the identifying characteristics thereof.
3 . The feed additive formulation of claim 1 , wherein the xylanase is an endo-1,4-beta-xylanase.
4 . The feed additive formulation of claim 1 , wherein the formulation is a solid, a powder, a suspension concentrate, a liquid, or a granule.
5 . The feed additive formulation of claim 1 , further comprising a carrier.
6 . The feed additive formulation of claim 5 , wherein the carrier comprises limestone.
7 . The feed additive formulation of claim 1 , wherein the xylanase ranges from 10,000-200,000 units/gram and the Bacillus licheniformis ranges from 10 8 -10 12 CFU/gram.
8 . The feed additive formulation of claim 2 , wherein the xylanase ranges from 10,000-200,000 units/gram, the Bacillus licheniformis ranges from 10 8 -10 12 CFU/gram, and the Bacillus amyloliquefaciens ranges from 10 8 -10 12 CFU/gram.
9 . A feed composition for monogastric animals comprising the feed additive formulation of claim 1 .
10 . The feed composition of claim 9 , further comprising a biologically pure culture of a Bacillus amyloliquefaciens strain Ba-BPD1 (Accession No. DSM 21836), or a mutant thereof having all the identifying characteristics thereof.
11 . The feed composition of claim 9 , wherein the xylanase ranges from 5-30 units/gram feed and the Bacillus licheniformis ranges from at least 5×10 4 CFU/gram feed.
12 . The feed composition of claim 10 , wherein the xylanase ranges from 5-30 units/gram feed and each of the Bacillus licheniformis and the Bacillus amyloliquefaciens ranges from at least 10 5 CFU/gram feed for a total of at least 1×10 5 CFU/gram feed.
13 . A method for increasing the performance of a monogastric animal comprising:
administering to the monogastric animal an effective amount of a feed composition comprising a xylanase enzyme and a biologically pure culture of a Bacillus licheniformis strain PWD-1 (Accession No. 53757), or a mutant thereof having all the identifying characteristics thereof.
14 . The method of claim 13 , wherein the feed composition further comprises a biologically pure culture of a Bacillus amyloliquefaciens strain Ba-BPD1 (Accession No. DSM 21836), or a mutant thereof having all the identifying characteristics thereof.
15 . The method of claim 13 , wherein the xylanase is an endo-1,4-beta-xylanase.
16 . The method of claim 13 , wherein the animal is poultry.
17 . The method of claim 16 , wherein the animal is a broiler.
18 . The method of claim 13 , wherein the animal is swine.
19 . The method of claim 13 , wherein the increase in performance comprises one or a combination of: increased average daily weight gain, increased total weight gain, improved feed conversion rate, reduced lesion score, reduced mortality, reduced disease, or decreased pathogen incidence.
20 . The method of claim 19 , wherein one or both of the disease and lesion score is a result of one or a combination of Clostridium perfringens, Eimeria acervulina, Eimeria maxima, Eimeria tenella or Coccidiosis-inducing parasites.
21 . The method of claim 19 , wherein the animal is poultry and the increase in performance comprises reduced lesion score resulting from one or a combination of Clostridium perfringens or Eimeria spc.
22 . The method of claim 19 , wherein the animal is poultry and the decreased pathogen incidence is a decreased Salmonella incidence.
23 . A method of preparing a feed composition for monogastric animals, comprising adding to the feed composition a formulation comprising a xylanase enzyme and a biologically pure culture of a Bacillus licheniformis strain PWD-1 (Accession No. 53757), or a mutant thereof having all the identifying characteristics thereof.
24 . The method of claim 23 , wherein the formulation further comprises a biologically pure culture of a Bacillus amyloliquefaciens strain Ba-BPD1 (Accession No. DSM 21836), or a mutant thereof having all the identifying characteristics thereof.
25 . The method of claim 23 , wherein the xylanase is an endo-1,4-beta-xylanase.
26 . The method of claim 23 , wherein the formulation is a solid, a powder, a suspension concentrate, a liquid, or a granule.
27 . The method of claim 23 , wherein the xylanase ranges from 5-30 units/gram feed and the Bacillus licheniformis ranges from at least 5×10 4 CFU/gram feed.
28 . The method of claim 24 , wherein the xylanase ranges from 5-30 units/gram feed and each of the Bacillus licheniformis and the Bacillus amyloliquefaciens ranges from at least 10 5 CFU/gram feed for a total of at least 1×10 5 CFU/gram feed.Join the waitlist — get patent alerts
Track US2022133816A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.